HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stig Palm Selected Research

Astatine-211

7/2022Estimating the risk for secondary cancer following targeted alpha therapy with astatine-211 intraperitoneal radioimmunotherapy.
1/2021Evaluation of therapeutic efficacy of 211At-labeled farletuzumab in an intraperitoneal mouse model of disseminated ovarian cancer.
11/2019Towards elucidating the radiochemistry of astatine - Behavior in chloroform.
1/2019Labeling of Anti-HER2 Nanobodies with Astatine-211: Optimization and the Effect of Different Coupling Reagents on Their in Vivo Behavior.
3/2016Synthesis and Evaluation of Astatinated N-[2-(Maleimido)ethyl]-3-(trimethylstannyl)benzamide Immunoconjugates.
7/2015Automated astatination of biomolecules--a stepping stone towards multicenter clinical trials.
10/2007Therapeutic efficacy of astatine-211-labeled trastuzumab on radioresistant SKOV-3 tumors in nude mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stig Palm Research Topics

Disease

25Neoplasms (Cancer)
07/2022 - 03/2003
13Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 09/2003
5Carcinoma (Carcinomatosis)
01/2017 - 07/2003
3Ascites
12/2017 - 11/2005
2Ovarian Epithelial Carcinoma
07/2022 - 01/2019
2Residual Neoplasm
02/2020 - 11/2015
2Body Weight (Weight, Body)
02/2020 - 12/2017
2Breast Neoplasms (Breast Cancer)
06/2008 - 07/2004
1Neoplasm Metastasis (Metastasis)
02/2020
1Prostatic Neoplasms (Prostate Cancer)
02/2020
1Fatigue
01/2019
1Intestinal Perforation
01/2019
1Anus Neoplasms (Anal Cancer)
06/2018
1Neoplasm Micrometastasis
08/2013

Drug/Important Bio-Agent (IBA)

10Monoclonal AntibodiesIBA
01/2019 - 03/2003
7Astatine-211IBA
07/2022 - 10/2007
5211At-labeled monoclonal antibody MX35IBA
01/2021 - 08/2006
5AntibodiesIBA
01/2021 - 09/2003
4Trastuzumab (Herceptin)FDA Link
06/2008 - 07/2003
3Radioisotopes (Radionuclides)IBA
01/2018 - 06/2008
3Immunoconjugates (Immunoconjugate)IBA
03/2016 - 12/2005
3Biological ProductsIBA
08/2013 - 03/2003
2AntigensIBA
02/2020 - 01/2019
2AstatineIBA
03/2016 - 07/2015
2EpitopesIBA
01/2015 - 09/2003
1Contrast MediaIBA
07/2022
1Colloids (Colloid)IBA
07/2022
1Thorium Dioxide (Thorotrast)IBA
07/2022
1Rituximab (Mabthera)FDA Link
01/2021
1farletuzumabIBA
01/2021
1Membrane Glycoproteins (Membrane Glycoprotein)IBA
02/2020
1Indicators and Reagents (Reagents)IBA
01/2019
1TinIBA
03/2016
1Neoplasm Antigens (Tumor Antigens)IBA
01/2015
1Hematoxylin (Haematoxylon)IBA
08/2013
1Eosine Yellowish-(YS) (Eosin)IBA
08/2013
1Liposomes (Liposome)IBA
12/2010
1Pharmaceutical PreparationsIBA
12/2010
1Actinium-225IBA
07/2004
1SuspensionsIBA
03/2003

Therapy/Procedure

16Therapeutics
07/2022 - 06/2008
14Radioimmunotherapy
07/2022 - 09/2003
5Aftercare (After-Treatment)
02/2020 - 11/2005
4Drug Therapy (Chemotherapy)
07/2022 - 07/2009
2Intravenous Injections
01/2021 - 01/2017
2Catheters
01/2019 - 07/2009
2Radiotherapy
06/2018 - 06/2008
1Castration
02/2020
1Transcutaneous Electric Nerve Stimulation (TENS)
08/2013
1Intraperitoneal Injections
07/2003